CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Spain

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Spain


  • Products Id :- GDHC0076CHR
  • |
  • Pages: 265
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Spain

Summary

GlobalData, the industry analysis specialist has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Spain". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Spain. It identifies the key trends in the country's healthcare market, and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Spain has strong healthcare infrastructure and the Spanish National Health System provides free healthcare for all citizens. In 2015, Spain spent approximately $1.2 billion on R&D, and exported approximately $11.5 billion of pharmaceuticals.

The pharmaceutical market was worth approximately $25.1 billion in 2008, and declined to approximately $23.7 billion in 2016 and is expected to reach $25.1 billion in 2021, registering a CAGR of 0.9% between 2017 and 2021. The primary reasons for this decline are the austerity measures implemented by the Spanish government.

The factors influencing the pharmaceutical market are

The consolidation of the biotechnology sector and an established pharmaceutical industry, which is the leading recipient of R&D spending in Spain

Government support: The provision of financial aid for foreign technology companies

Excellent infrastructure for innovation: The exponential growth of science and technology parks (nearly 80), research centers and institutes of technology and the incorporation of the latest technology for life science projects

Highly qualified workforce: Large percentage of workers with post-graduate qualifications

Favorable cost-benefit ratio of human capita: Low salaries and high demand for jobs in the scientific or biotech industry .

The medical device market was valued at $7.8billion in 2009, and is projected to grow at a CAGR of 4.5% to an estimated $12.3 billion in 2021.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Spain, and includes

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sanofi, GSK and Merck & Co., as well as profiles and SWOT analyses of the major players in the medical device market: GSK,Baxter International, Johnson & Johnson, Svenska Cellulosa Aktiebolaget and Paul Hartmann

Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to

Develop business strategies by understanding the trends shaping and driving the Spanish healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect the Spanish healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships

Identify, understand, and capitalize on the opportunities and challenges in the Spanish healthcare market



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Executive Summary 10

3 Introduction 16

3.1 GlobalData Report Guidance 16

4 Overview of Pharmaceutical and Medical Device Markets 17

4.1 Pharmaceutical Market 17

4.1.1 Market Overview 17

4.1.2 Pharmaceutical Exports and Imports 20

4.1.3 Supply Channels 22

4.1.4 Market Segments 23

4.1.5 Major Therapeutic Areas 31

4.1.6 Major Players 34

4.2 Medical Device Market 71

4.2.1 Market Overview 71

4.2.2 Overview of Top Five Segments 74

4.2.3 Diagnostic Market 84

4.2.4 Major Players 87

4.3 Market Drivers and Barriers 114

4.3.1 Drivers 114

4.3.2 Barriers 115

5 Market Access 117

5.1 Reimbursement and Payer Landscape 117

5.1.1 Overview of Healthcare System 117

5.1.2 Reimbursement Process 118

5.1.3 Overview of Insurance Providers 121

5.1.4 Patient Share in Healthcare Expenditure 123

5.1.5 Price Trends in the Healthcare Sector 124

5.1.6 Pricing Policies 125

5.2 Regulatory Landscape 128

5.2.1 Overview of Regulatory Agencies 128

5.2.2 Market Authorization Procedure for Pharmaceutical Products 130

5.2.3 New Medical Device Approval Process 142

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 146

5.2.5 Licensing Process for Pharmaceutical Exports and Imports 149

5.2.6 Intellectual Property Rights 150

5.2.7 Clinical Trial Regulations 155

5.2.8 Pharmaceutical Advertising Regulations 156

5.2.9 Pharmacy Regulations 160

5.2.10 Labeling and Packaging Regulations 162

6 Country Analysis 164

6.1 Political Environment 164

6.1.1 Political Structure 164

6.1.2 Current Political Environment 165

6.1.3 Healthcare Policy Initiatives 166

6.2 Economic Landscape 168

6.3 Economic Indicators 173

6.3.1 Gross Domestic Product 173

6.3.2 Gross National Income 178

6.3.3 Inflation 179

6.3.4 Currency Exchange Rate 182

6.3.5 Foreign Direct Investment 183

6.3.6 Foreign Exchange Reserves 184

6.3.7 Trade Balance 185

6.3.8 Government Structural Balance 187

6.3.9 Government Net Debt 188

6.3.10 Major Industries 189

6.4 Demographics 191

6.4.1 Population 191

6.4.2 Education and Literacy 209

6.4.3 Employment 213

6.4.4 Disease Burden 214

6.5 Healthcare Infrastructure 217

6.5.1 Healthcare Facilities 217

6.5.2 Healthcare Parameters 224

6.5.3 Environmental Health 227

6.5.4 Healthcare Personnel 231

6.6 Healthcare Expenditure 235

6.6.1 Overview 235

6.6.2 Share of Public and Private Sectors 236

6.6.3 Major Components of Healthcare Expenditure 237

6.6.4 Spending in R&D 237

6.7 Trade Associations 238

6.7.1 Farmaindustria 238

6.7.2 The Spanish Society of Public Health and Health Services Administration 239

6.7.3 The Spanish Society of Health Informatics 239

6.7.4 Spanish Generic Medicines Association 240

6.8 Trade Fairs 240

7 Opportunities and Challenges 241

7.1 Opportunities 241

7.2 Challenges 242

8 Appendix 244

8.1 Abbreviations 244

8.2 Bibliography 248

8.3 Research Methodology 263

8.3.1 Coverage 263

8.3.2 Secondary Research 263

8.3.3 Forecasts 264

8.3.4 Expert Panel 264

8.4 Contact Us 264

8.5 Disclaimer 265

1.2 List of Figures

Figure 1: Pharmaceutical Market, Spain, Revenue ($bn), 2009-2021 11

Figure 2: Medical Device Market, Spain, Revenue ($bn), 2009-2021 12

Figure 3: Country Profile, Spain, 2017 15

Figure 4: Pharmaceutical Market, Spain, Revenue ($bn), 2009-2016 19

Figure 5: Pharmaceutical Market, Spain, Revenue ($bn), 2017-2021 20

Figure 6: Pharmaceutical Market, Spain, Exports and Imports ($bn), 2009-2016 21

Figure 7: Pharmaceutical Market, Spain, Distribution Channels for Pharmaceuticals (%), 2012 23

Figure 8: Pharmaceutical Market, Spain, Generic Pharmaceutical Market Share (%), 2009-2016 25

Figure 9 Pharmaceutical Market, Spain, Red Biotechnology, Share of Diagnostics Pipeline by Disease Area (%), 2016 27

Figure 10 Pharmaceutical Market, Spain, Red Biotechnology, Share of Therapeutics Pipeline by Disease Area (%), 2016 28

Figure 11: Pharmaceutical Market, Spain, OTC Drug Market Revenue ($bn), 2009-2016 30

Figure 12: Pharmaceutical Market, Spain, Market Share of Major OTC Drug Classes (%), 2015 31

Figure 13: Pharmaceutical Market, Spain, Major Therapeutic Areas by Units Sold (millions), 2015 32

Figure 14: Medical Device Market, Spain, Revenue ($bn), 2009-2016 72

Figure 15: Medical Device Market, Spain, Revenue ($bn), 2017-2021 73

Figure 16: Medical Device Market, Spain, Revenue by Segment ($m), 2016 74

Figure 17: In Vitro Diagnostics Market, Spain, Revenue ($m), 2009-2016 75

Figure 18: In Vitro Diagnostics, Spain, Market Share of Major Players (%), 2014 76

Figure 19: Diabetes Care Device Market, Spain, Revenue ($m), 2009-2016 77

Figure 20: : Diabetes Care Device Market, Spain, Market Share of Major Players (%), 2015 78

Figure 21: Ophthalmic Device Market, Spain, Revenue ($m), 2009-2016 79

Figure 22: Ophthalmic Devices, Spain, Market Share of Major Players (%), 2015 80

Figure 23: Orthopedic Devices, Spain, Revenue ($m), 2009-2016 81

Figure 24: Orthopedic Devices, Spain, Market Share of Major Players (%), 2016 82

Figure 25: Hospital Supplies Market, Spain, Revenue ($m), 2009-2016 83

Figure 26: Hospital Supplies Market, Spain, Market Share of Major Players (%), 2014 84

Figure 27: Medical Device Market, Spain, Diagnostic Market, Revenue ($bn), 2009-2016 85

Figure 28: Medical Device Market, Spain, Diagnostic Market, Revenue ($bn), 2017-2021 86

Figure 29: Medical Device Market, Spain, Revenue of Major Players ($m), 2012 87

Figure 30: Healthcare Market, Spain, Drivers and Barriers, 2017 116

Figure 31: Market Access, Spain, Healthcare System, 2014 117

Figure 32: Healthcare System, Spain, Health Technology Assessment Process, 2014 120

Figure 33: Healthcare Expenditure, Spain, Out-of-Pocket Expenditure as Percentage of Total Expenditure (%), 2009-2016 123

Figure 34: Market Access, Spain, Healthcare Consumer Price Index Annual Change (%), 2009-2016 124

Figure 35: Market Access, Spain, Organizational Structure of AEMPS, 2016 130

Figure 36: Market Access, Spain, National Procedure, 2014 133

Figure 37: Market Access, EU, Centralized Procedure for Market Authorization, Pre-submission, 2016 135

Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Pre-opinion Phase, 2016 137

Figure 39: Market Access, EU, Centralized Procedure, Market Authorization, Post-opinion Phase, 2016 138

Figure 40: Market Access, EU, Decentralized Procedure, Market Authorization, 2016 140

Figure 41: Market Access, EU, Mutual Recognition Procedure, 2016 141

Figure 42: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2016 143

Figure 43: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2016 144

Figure 44: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2016 145

Figure 45: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2016 146

Figure 46: Economic Indicators, Spain, GDP per Capita ($), 2009-2016 174

Figure 47: Economic Indicators, Spain, GDP per Capita ($), 2017-2021 175

Figure 48: Economic Indicators, Spain, GDP Annual Growth (%), 2009-2016 176

Figure 49: Economic Indicators, Spain, GDP Annual Growth (%), 2017-2021 177

Figure 50: Economic Indicators, Spain, GNI per Capita ($), 2009-2016 178

Figure 51: Economic Indicators, Spain, Consumer Price Index, 2009-2016 179

Figure 52: Economic Indicators, Spain, Average Consumer Price Index, 2017-2021 180

Figure 53: Economic Indicators, Spain, Average Consumer Price Index, Annual Change (%), 2009-2016 181

Figure 54: Economic Indicators, Spain, Currency Exchange Rate (EUR/$), 2009-2016 182

Figure 55: Economic Indicators, Spain, Foreign Direct Investment ($bn), 2009-2016 183

Figure 56: Economic Indicators, Spain, Foreign Exchange Reserves ($bn), 2009-2016 184

Figure 57: Economic Indicators, Spain, Imports of Goods and Services ($bn), 2009-2016 185

Figure 58: Economic Indicators, Spain, Exports of Goods and Services ($bn), 2009-2016 186

Figure 59: Economic Indicators, Spain, Government Structural Balance ($bn), 2009-2016 187

Figure 60: Economic Indicators, Spain, Government Net Debt as Percentage of GDP (%), 2009-2016 188

Figure 61: Economic Indicators, Spain, Government Net Debt as Percentage of GDP (%), 2017-2021 189

Figure 62: Economic Indicators, Spain, Major Industries by Revenue ($bn), 2014 190

Figure 63: Demographics, Spain, Population (million), 2009-2016 192

Figure 64: Demographics, Spain, Population (million), 2017-2021 193

Figure 65: Demographics, Spain, Urban-Rural Population Share (%), 2009-2016 194

Figure 66: Demographics, Spain, Urban-Rural Population Share (%), 2017-2021 195

Figure 67: Demographics, Spain, Population Distribution by Age Group (%), 2009-2016 196

Figure 68: Demographics, Spain, Population Distribution by Age Group (%), 2017-2021 197

Figure 69: Demographics, Spain, Births (per 1,000 population), 2009-2016 198

Figure 70: Demographics, Spain, Mortality (per 1,000 population), 2009-2016 199

Figure 71: Demographics, Spain, Major Causes of Mortality , 2013 200

Figure 72: Demographics, Spain, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 202

Figure 73: Demographics, Spain, Immunization Rate (%), 2009-2016 203

Figure 74: Demographics, Spain, Major Causes of Male Mortality 2013 204

Figure 75: Demographics, Spain, Major Causes of Female Mortality, 2013 206

Figure 76: Demographics, Spain, Gender Ratio (M/F), 2009-2016 207

Figure 77: Demographics, Spain, Life Expectancy at Birth (years), 2009-2016 208

Figure 78: Demographics, Spain, Students Enrolled at Different Levels in Non-university Courses (%), 2014-2015 210

Figure 79: Demographics, Spain, Students Enrolled at Different Levels in University Courses (%), 2013-2014 211

Figure 80: Demographics, Spain, Unemployment Rate (%), 2009-2016 213

Figure 81: Demographics, Spain, Distribution of Employment by Sector (%), 2015 214

Figure 82: Demographics, Spain, Number of Hospital Admissions and Diseases Diagnosed, 2015 215

Figure 83: Demographics, Spain, Major Diseases, Disability-Adjusted Life Years (000'), 2014 216

Figure 84: Healthcare Infrastructure, Spain, Hospitals, 2009-2016 218

Figure 85: Healthcare Infrastructure, Spain, Number of Hospitals by Type of Treatment, 2009-2016 219

Figure 86: Healthcare Infrastructure, Spain, Number of Hospitals by Sector, 2009-2016 220

Figure 87: Healthcare Infrastructure, Spain, Number of Hospital Beds by Sector, 2009-2016 221

Figure 88: Healthcare Infrastructure, Spain, Hospital Beds by Type of Treatment Provided, 2009-2016 222

Figure 89: Healthcare Infrastructure, Spain, Diagnostic Units (per 100,000 population), 2009-2016 223

Figure 90: Healthcare Infrastructure, Spain, Hospitals Beds (per 1,000 population), 2009-2016 225

Figure 91: Healthcare Infrastructure, Spain, Doctors (per 1,000 population), 2009-2016 226

Figure 92: Healthcare Infrastructure, Spain, PM2.5 (g per m), 2009-2016 228

Figure 93: Healthcare Infrastructure, Spain, CO2 Emissions (metric tons per capita), 2009-2016 230

Figure 94: Healthcare Infrastructure, Spain, Nurses, 2009-2016 231

Figure 95: Healthcare Infrastructure, Spain, Pharmacists, 2009-2016 232

Figure 96: Healthcare Infrastructure, Spain, Dentists, 2009-2016 233

Figure 97: Healthcare Infrastructure, Spain, Qualified Midwives, 2009-2016 234

Figure 98: Healthcare Infrastructure, Spain, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 235

Figure 99: Healthcare Infrastructure, Spain, Public-Private Share of Expenditure (%), 2009-2016 236

Figure 100: Healthcare Infrastructure, Spain, Major Components of Healthcare Expenditure (%), 2015 237

Figure 101: Healthcare Infrastructure, Spain, R&D Expenditure by Field (%), 2013 238

Figure 102: Healthcare Market, Spain, Opportunities and Challenges, 2017 243

1.1 List of Tables

Table 1: Pharmaceutical Market, Spain, Revenue ($bn), 2009-2016 19

Table 2: Pharmaceutical Market, Spain, Revenue ($bn), 2017-2021 20

Table 3: Pharmaceutical Market, Spain, Exports and Imports ($bn), 2009-2016 21

Table 4: Pharmaceutical Market, Spain, Generic Pharmaceutical Market Share (%), 2009-2016 25

Table 8: Pharmaceutical Market, Spain, Red Biotechnology, Share of Diagnostics Pipeline by Disease Area (%), 2016 27

Table 8: Pharmaceutical Market, Spain, Red Biotechnology, Share of Therapeutics Pipeline by Disease Area (%), 2016 29

Table 7: Pharmaceutical Market, Spain, OTC Drug Market Revenue ($bn), 2009-2016 30

Table 8: Pharmaceutical Market, Spain, Major OTC Drug Classes, Revenue ($bn) and Market Share (%), 2015 31

Table 9: Pharmaceutical Market, Spain, Major Therapeutic Areas by Units Sold (millions) and Share (%), 2015 32

Table 10: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016 35

Table 11: Major Products, Novartis, Global, 2016 41

Table 12: Late-Stage Pipeline, Novartis, Global, 2015 42

Table 13: Major Products, Sanofi, Global, 2015 50

Table 14: Late-Stage Pipeline, Sanofi, Global, 2015 52

Table 15: Pharmaceutical Market, Merck & Co., Global, Major Products, 2015 64

Table 16: Pharmaceutical Market, Merck & Co., Global, Late-Stage Pipeline, 2016 66

Table 17: Medical Device Market, Spain, Revenue ($bn), 2009-2016 72

Table 18: Medical Device Market, Spain, Revenue ($bn), 2017-2021 73

Table 19: Medical Device Market, Spain, Revenue ($m) and Market Share (%) by Segment, 2016 74

Table 20: In Vitro Diagnostics Market, Spain, Revenue ($m), 2009-2016 76

Table 21: In Vitro Diagnostics, Spain, Revenue ($m) and Market Share (%) of Major Players, 2014 76

Table 22: Diabetes Care Device Market, Spain, Revenue ($m), 2009-2016 77

Table 23: Diabetes Care Devices, Spain, Revenue ($m) and Market Share (%) of Major Players, 2015 78

Table 24: Ophthalmic Device Market, Spain, Revenue ($m), 2009-2016 79

Table 25: Ophthalmic Devices, Spain, Revenue ($m) and Market Share (%) of Major Players, 2015 80

Table 26: Orthopedic Devices, Spain, Revenue ($m), 2009-2016 81

Table 27: Orthopedic Devices, Spain, Revenue ($m) and Market Share (%) of Major Players, 2016 82

Table 28: Hospital Supplies Market, Spain, Revenue ($m), 2009-2016 83

Table 29: Hospital Supplies Market, Spain, Revenue ($m) and Market Share (%) of Major Players, 2014 84

Table 30: Medical Device Market, Spain, Diagnostic Market, Revenue ($bn), 2009-2016 85

Table 31: Medical Device Market, Spain, Revenue ($bn), 2017-2021 86

Table 32: Medical Device Market, Spain, Revenue ($m) and Market Share (%) of Major Players, 2012 87

Table 33: Baxter International, Global, Major Products, 2016 95

Table 34: Paul Hartmann, Global, Major Products, 2016 110

Table 35: Healthcare System, Spain, Pharmaceutical Reimbursement Categories, 2014 119

Table 36: Healthcare Expenditure, Spain, Out-of-Pocket Expenditure as Percentage of Total Expenditure (%), 2009-2016 123

Table 37: Market Access, Spain, Healthcare Consumer Price Index Annual Change (%), 2009-2016 125

Table 38: Economic Indicators, Spain, GDP per Capita ($), 2009-2016 174

Table 39: Economic Indicators, Spain, GDP per Capita ($), 2017-2021 175

Table 40: Economic Indicators, Spain, GDP Annual Growth (%), 2009-2016 176

Table 41: Economic Indicators, Spain, GDP Annual Growth (%), 2017-2021 177

Table 42: Economic Indicators, Spain, GNI per Capita ($), 2009-2016 178

Table 43: Economic Indicators, Spain, Consumer Price Index, 2009-2016 179

Table 44: Economic Indicators, Spain, Average Consumer Price Index, 2017-2021 180

Table 45: Economic Indicators, Spain, Average Consumer Price Index Annual Change (%), 2009-2016 181

Table 46: Economic Indicators, Spain, Currency Exchange Rate (EUR/$), 2009-2016 182

Table 47: Economic Indicators, Spain, Foreign Direct Investment ($bn), 2009-2016 183

Table 48: Economic Indicators, Spain, Foreign Exchange Reserves ($bn), 2009-2016 184

Table 49: Economic Indicators, Spain, Imports of Goods and Services ($bn), 2009-2016 185

Table 50: Economic Indicators, Spain, Exports of Goods and Services ($bn), 2009-2016 186

Table 51: Economic Indicators, Spain, General Government Structural Balance ($bn), 2009-2016 187

Table 52: Economic Indicators, Spain, Government Net Debt as Percentage of GDP (%), 2009-2016 188

Table 53: Economic Indicators, Spain, Government Net Debt as Percentage of GDP (%), 2017-2021 189

Table 54: Economic Indicators, Spain, Major Industries by Revenue ($bn), 2014 190

Table 55: Demographics, Spain, Population (million), 2009-2016 192

Table 56: Demographics, Spain, Population (million), 2017-2021 193

Table 57: Demographics, Spain, Urban-Rural Population Share (%), 2009-2016 194

Table 58: Demographics, Spain, Urban-Rural Population Share (%), 2017-2021 195

Table 59: Demographics, Spain, Population Distribution by Age Group (%), 2009-2016 196

Table 60: Demographics, Spain, Population Distribution by Age Group (%), 2017-2021 197

Table 61: Demographics, Spain, Births (per 1,000 population), 2009-2016 198

Table 62: Demographics, Spain, Mortality (per 1,000 population), 2009-2016 199

Table 63: Demographics, Spain, Major Causes of Mortality (%), 2013 201

Table 64: Demographics, Spain, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 202

Table 65: Demographics, Spain, Immunization Rate (%), 2009-2016 203

Table 66: Demographics, Spain, Major Causes of Male Mortality, 2013 205

Table 67: Demographics, Spain, Major Causes of Female Mortality (%), 2012 206

Table 68: Demographics, Spain, Gender Ratio (M/F), 2009-2016 207

Table 69: Demographics, Spain, Life Expectancy at Birth (years), 2009-2016 209

Table 70: Demographics, Spain, Students Enrolled at Different Levels in Non-university Courses (%), 2014-2015 211

Table 71: Demographics, Spain, Students Enrolled at Different Levels in University Courses (%), 2013-2014 212

Table 72: Demographics, Spain, Unemployment Rate (%), 2009-2016 213

Table 73: Demographics, Spain, Distribution of Employment by Sector (%), 2015 214

Table 74: Demographics, Spain, Number of Hospital Admissions and Diseases Diagnosed, 2015 215

Table 75: Demographics, Spain, Major Diseases, Disability-Adjusted Life Years (000'), 2014 217

Table 76: Healthcare Infrastructure, Spain, Hospitals, 2009-2016 218

Table 77: Healthcare Infrastructure, Spain, Number of Hospitals by Type of Treatment, 2009-2016 219

Table 78: Healthcare Infrastructure, Spain, Number of Hospitals by Sector, 2009-2016 220

Table 79: Healthcare Infrastructure, Spain, Number of Hospital Beds by Sector, 2009-2016 221

Table 80: Healthcare Infrastructure, Spain, Hospital Beds by Type of Treatment Provided, 2009-2016 222

Table 81: Healthcare Infrastructure, Spain, Diagnostic Units (per 100,000 population), 2009-2016 224

Table 83: Healthcare Infrastructure, Spain, Hospital Beds (per 1,000 population), 2009-2016 225

Table 83: Healthcare Infrastructure, Spain, Doctors (per 1,000 population), 2009-2016 226

Table 84: Healthcare Infrastructure, Spain, PM2.5 (g per m), 2009-2016 228

Table 85: Healthcare Infrastructure, Spain, CO2 Emissions (metric tons per capita), 2009-2016 230

Table 86: Healthcare Infrastructure, Spain, Nurses, 2009-2016 231

Table 87: Healthcare Infrastructure, Spain, Pharmacists, 2009-2016 232

Table 88: Healthcare Infrastructure, Spain, Dentists, 2009-2016 233

Table 89: Healthcare Infrastructure, Spain, Qualified Midwives, 2009-2016 234

Table 90: Healthcare Infrastructure, Spain, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 235

Table 91: Healthcare Infrastructure, Spain, Public-Private Share of Expenditure (%), 2009-2016 236

Table 92: Healthcare Infrastructure, Spain, Major Components of Healthcare Expenditure (%), 2015 237

Table 93: Healthcare Infrastructure, Spain, R&D Expenditure by Field (%), 2013 238

Table 94: Healthcare Expenditure, Spain, Major Healthcare Trade Fairs, 2017 240

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GSK, Baxter, Johnson & Johnson, Svenska Cellulosa Aktiebolaget, Paul Hartmann

Spain,Country Analysis,PoliticalLandscape, Economic Landscape, Pharmaceutical and Medical Device markets, Regulatory landscape, Reimbursement landscape, Drivers and Barriers, oppurtunities and challenges

select a license

Single User License
USD 1995 INR 129775
Site License
USD 3990 INR 259550
Corporate User License
USD 5985 INR 389324

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com